HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
+7.33%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$964M
AUM Growth
+$964M
(+4%)
Cap. Flow
-$30.7M
Cap. Flow
% of AUM
-3.19%
Top 10 Holdings %
Top 10 Hldgs %
63.3%
Holding
123
New
7
Increased
13
Reduced
13
Closed
12
Top Buys
| 1 |
Berkshire Hathaway Class A
BRK.A
|
$3.4M |
| 2 |
Alphabet (Google) Class C
GOOG
|
$2.89M |
| 3 |
Altria Group
MO
|
$1.1M |
| 4 |
Vanguard S&P 500 ETF
VOO
|
$991K |
| 5 |
RDS.B
Royal Dutch Shell PLC ADS Class B
RDS.B
|
$687K |
Top Sells
| 1 |
GE Aerospace
GE
|
$8.19M |
| 2 |
Novo Nordisk
NVO
|
$5.55M |
| 3 |
Procter & Gamble
PG
|
$4.11M |
| 4 |
Gilead Sciences
GILD
|
$4.07M |
| 5 |
Biogen
BIIB
|
$3.94M |
Sector Composition
| 1 | Financials | 41.99% |
| 2 | Healthcare | 19.01% |
| 3 | Industrials | 7.19% |
| 4 | Materials | 5% |
| 5 | Technology | 4.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
STOR
51
DELISTED
STORE Capital Corporation
STOR
| $1.37M | 0.14% |
36,700
| – | – |
|
52
Nasdaq
NDAQ
$53.8B
| $1.2M | 0.12% |
11,200
| – | – |
|
53
Anavex Life Sciences
AVXL
$817M
| $1.11M | 0.12% |
429,200
-38,910
| -8% | -$101K |
|
54
MetLife
MET
$53.6B
| $1.06M | 0.11% |
20,760
| – | – |
|
55
British American Tobacco
BTI
$120B
| $919K | 0.1% |
21,650
+2,300
| +12% | +$97.6K |
|
|
ALPN
56
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| $712K | 0.07% |
185,287
-300
| -0.2% | -$1.15K |
|
|
SRCL
57
DELISTED
Stericycle Inc
SRCL
| $676K | 0.07% |
10,600
-48,800
| -82% | -$3.11M |
|
58
Omnicom Group
OMC
$15B
| $654K | 0.07% |
8,070
| – | – |
|
|
59
Berkshire Hathaway Class B
BRK.B
$1.08T
| $612K | 0.06% |
2,700
| – | – |
|
60
Zoetis
ZTS
$67.6B
| $609K | 0.06% |
4,600
-4,400
| -49% | -$583K |
|
61
Dynavax Technologies
DVAX
$1.19B
| $604K | 0.06% |
105,573
| – | – |
|
|
62
GE Aerospace
GE
$293B
| $561K | 0.06% |
50,280
-734,420
| -94% | -$8.19M |
|
63
Stellantis
STLA
$26.4B
| $490K | 0.05% |
33,350
| – | – |
|
64
Aldeyra Therapeutics
ALDX
$350M
| $465K | 0.05% |
80,020
| – | – |
|
65
Corvus Pharmaceuticals
CRVS
$419M
| $435K | 0.05% |
80,000
-50,000
| -38% | -$272K |
|
|
WW
66
DELISTED
WW International
WW
| $405K | 0.04% |
10,600
| – | – |
|
67
Ecolab
ECL
$77.5B
| $405K | 0.04% |
2,100
| – | – |
|
68
General Mills
GIS
$26.6B
| $353K | 0.04% |
6,600
| – | – |
|
|
ERUS
69
DELISTED
iShares MSCI Russia ETF
ERUS
| $335K | 0.03% |
7,850
| – | – |
|
70
Thermo Fisher Scientific
TMO
$183B
| $325K | 0.03% |
1,000
| – | – |
|
|
PARA
71
DELISTED
Paramount Global Class B
PARA
| $325K | 0.03% |
+7,755
| New | +$325K |
|
72
DaVita
DVA
$9.72B
| $302K | 0.03% |
4,020
-38,400
| -91% | -$2.88M |
|
73
Lam Research
LRCX
$124B
| $298K | 0.03% |
1,020
| – | – |
|
74
KLA
KLAC
$111B
| $287K | 0.03% |
1,610
| – | – |
|
75
Applied Materials
AMAT
$124B
| $283K | 0.03% |
4,630
| – | – |
|